Ikonisys specializes in the development and commercialization of next generation, non-invasive, rare cell-based diagnostics based on the utilization of its innovative CellOptics® platform, which has been developed to enable commercial diagnostic labs the capability to offer rare cell-based tests in a practical manner. The platform includes an enabling component -- the Ikoniscope® robotic microscopy system for fully-automated, high-throughput identification and analysis of rare cells -- that enables the commercial lab to perform the tests within the required quality, time and cost parameters.
Ikonisys, Inc.
New Haven, CT
President/CEO: Paul White
www.ikonisys.com
Recent Comments